HIV-1 integrase as a target for antiviral drugs

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue 6, 1997, Pages 463-483

  Pommier, Y ^a   Pilon, A A ^a   Bajaj, K ^a   Mazumder, A ^a   Neamati, N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AIDS; Chemotherapy; Drug design; Hydroxylated aromatics; Inhibitors; Integrase; Nucleotides

Indexed keywords

ENZYME INHIBITOR; INTEGRASE;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMOTHERAPY; DNA BINDING; DNA SEQUENCE; DNA STRUCTURE; DRUG DESIGN; ENZYME ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE CYCLE; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS;

EID: 0030865411     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029700800601     Document Type: Article

References (180)

1. Allen P, Worland S & Gold L (1995) Isolation of high-affinity RNA ligands to HIV1 integrase from a random pool. Virology 209: 327-336.
2. Andrake MD & Skalka AM (1995) Multimerization determinants reside in both the catalytic core and C terminus of avian sarcoma virus integrase. Journal of Biological Chemistry 270: 29299-23006.
3. Andrake MD & Skalka AM (1996) Retroviral integrase, putting the pieces together. Journal of Biological Chemistry 271: 19633-19636.
4. Asante-Appiah E & Skalka AM (1997) A metal-induced conformational change and activation of HIV-1 integrase. Journal of Biological Chemistry 272: 16196-16205.
5. Balakrishnan M & Jonsson CB (1997) Functional identification of nucleotides conferring substrate specificity to retroviral integrase reactions. Journal of Virology 71: 1025-1035.
6. Barsov EV, Huber WE, Marcotrigiano J, Clark PK, Clark AD, Arnold E & Hughes SH (1996) Inhibition of human immunodeficiency virus type 1 integrase by the Fab fragment of a specific monoclonal antibody suggests that different multimerization states are required for different enzymatic functions. Journal of Virology 70: 4484-4494.
7. Beese LS, Derbyshire V & Steitz TA (1993) Structure of DNA polymerase I Klenow fragment bound to duplex DNA. Science 260: 352-355.
8. Billich A, Schauer M, Frank S, Rosenwirth B & Billich S (1992) HIV-1 integrase: high-level production and screening assay for the endonucleolytic activity. Antiviral Chemistry and Chemotherapy 3: 113-119.
9. Bizub-Bender D, Kulkosky J & Skalka AM (1994) Monoclonal antibodies against HIV type 1 integrase: clues to molecular structure. AIDS Research and Human Retroviruses 10: 1105-1115.
10. Bor YC, Miller MD, Bushman FD & Orgel LE (1996) Target-sequence preferences of HIV-1 integration complexes in vitro. Virology 222: 283-288.
11. Bouillé P, Subra F, Goulaouic H, Carteau S & Auclair C (1995) Impairment of Moloney murine leukemia virus integration in a cell line underexpressing DNA topoisomerase II. Cancer Research 55: 3211-3217.
12. Bouziane M, Cherny DI, Mouscadet J-F & Auclair C (1996) Alternate strand DNA triple helix-mediated inhibition of HIV-1 U5 long terminal repeat integration in vitro. Journal of Biological Chemistry 271: 10359-10364.
13. Bowerman B, Brown PO, Bishop JM & Varmus HE (1989) A nucleoprotein complex mediates the integration of retroviral DNA. Genes and Development 3: 469-478.
14. Brown PO (1990) Integration of retroviral DNA. Current Topics in Microbiology and Immunology 157: 19-48.
15. Bujacz G, Alexandratos J, Qing ZL, Clement-Mella C & Wlodawer A (1996a) The catalytic domain of human immunodeficiency virus integrase: ordered active site in the F185H mutant. FEBS Letters 398: 175-178.
16. Bujacz G, Jaskolski M, Alexandratos J, Wlodawer A, Merkel G, Katz RA & Skalka AM (1996b) The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations. Current Biology 4: 89-96.
17. Bujacz G, Alexandratos J, Wlodawer A, Merkel G, Andrake M, Katz RA & Skalka AM (1997) Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity. Journal of Biological Chemistry (in press).
18. Bukrinskaya AG, Ghorpade A, Heinzinger NK, Smithgall TE, Lewis RE & Stevenson M (1996) Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proceedings of the National Academy of Sciences, USA 93: 367-371.
19. Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, Haggerty S & Stevenson M (1992) Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proceedings of the National Academy of Sciences, USA 89: 6580-6584.
20. Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG & Stevenson M (1993a) Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proceedings of the National Academy of Sciences, USA 90: 6125-6129.
21. Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M & Stevenson M (1993b) A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365: 666-669.
22. Burke CJ, Sanyal G, Bruner MW, Ryan JA, LaFemina RL, Robbins HL, Zeft AS, Russell Middaugh C & Cordingley MG (1992) Structural implications of spectroscopic characterization of a putative zinc finger peptide from HIV-1 integrase. Journal of Biological Chemistry 267: 9639-9644.
23. Burke TR, Fesen M, Mazumder A, YungJ, Wang J, Carothers AM, Grunberger D, Driscoll J & Pommier Y (1995) Hydroxylated aromatic inhibitors of HIV-1 integrase. Journal of Medicinal Chemistry 38: 4171-4178.
24. Bushman FD & Craigie R (1991) Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proceedings of the National Academy of Sciences, USA 88: 1339-1343.
25. Bushman FD & Craigie R (1992) Integration of human immunodeficiency virus DNA: adduct interference analysis of required DNA sites. Proceedings of the National Academy of Sciences, USA 89: 3458-3462.
26. Bushman FD, Fujiwara T & Craigie R (1990) Retroviral DNA integration directed by HIV integration protein in vitro. Science 249: 1555-1558.
27. Bushman FD, Engelman A, Palmer I, Wingfield P & Craigie R (1993) Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proceedings of the National Academy of Sciences, USA 90: 3428-3432.
28. Cannon PM, Wilson W, Byles E, Kingsman SM & Kingsman AJK (1994) Human immunodeficiency virus type 1 integrase: effect on viral replication of mutation at highly conserved residues. Journal of Virology 68: 4768-4775.
29. Cannon PM, Byles ED, Kingsman SM & Kingsman AJ (1996) Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication. Journal of Virology 70: 651-657.
30. Carteau S, Mouscadet J-F, Goulaouic H, Subra F & Auclair C (1993a) Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction. Biochemical and Biophysical Research Communications 192: 1409-1414.
31. Carteau S, Mouscadet J-F, Goulaouic H, Subra F & Auclair C (1993b) Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction. Archives of Biochemistry and Biophysics 305: 606-610.
32. Carteau S, Mouscadet JF, Goulaouic H, Subra F & Auclair C (1994) Inhibition of the in vitro integration of Moloney murine leukemia virus DNA by the DNA minor groove binder netropsin. Biochemical Pharmacology 47: 1821-1826.
33. Chang YC, Ching TT & Syu WJ (1996) Assaying the activity of HIV-1 integrase with DNA-coated plates. Journal of Virological Methods 59: 135-140.
34. Chow SA & Brown PO (1994) Juxtaposition of two viral DNA ends in a bimolecular disintegration reaction mediated by multimers of human immunodeficiency virus type 1 or murine leukemia virus integrase. Journal of Virology 68: 7869-7878.
35. Chow SA, Vincent KA, Ellison V & Brown PO (1992) Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science 255: 723-726.
36. Craigie R, Mizuuchi K, Bushman FD & Engelman A (1991) A rapid in vitro assay for HIV DNA integration. Nucleic Acids Research 19: 2729-2734.
37. Cushman M & Sherman P (1992) Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. Biochemical and Biophysical Research Communications 185: 85-90.
38. Cushman M, Golebiewski WM, Pommier Y, Mazumder A, Reymen D, De Clercq E, Graham L & Rice WG (1995) Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase. Journal of Medicinal Chemistry 38: 443-452.
39. Dingwall C & Laskey RA (1991) Nuclear targeting sequences - a consensus? Trends in Biochemical Sciences 16: 478-481.
40. Donzella GA, Jonsson CB & Roth MJ (1993) Influence of substrate structure on disintegration activity of Moloney murine leukemia virus integrase. Journal of Virology 67: 7077-7087.
41. Drake R, Neamati N, Sunthankar P, Mazumder A & Pommier Y (1997) Identification of the antiviral nucleoside drug binding site of HIV-1 integrase by proteolytic peptide mapping. Antiviral Research 34: A42.
42. Drelich M, Wilhelm R & Mous J (1992) Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 protein in vitro. Virology 188: 459-468.
43. Dyda F, Hickman AB, Jenkins TM, Engelman A, Craigie R & Davies DR (1994) Crystal structure of the catalytic domain of HIV-1 integrase: similarity of other polynucleotide transferases. Science 266: 1981-1986.
44. Eich E, Petz H, Kaloga M, Schulz J, Fesen MR, Mazumder A & Pommier Y (1996) (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. Journal of Medicinal Chemistry 39: 86-95.
45. Eijkelenboom AP, Lutzke RA, Boelens R, Plasterk RH, Kaptein R & Hard K (1995) The DNA-binding domain of HIV-1 integrase has an SH3-like fold. Nature Structural Biology 2: 807-810.
46. Ellison V & Brown PO (1994) A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro. Proceedings of the National Academy of Sciences, USA 91: 7316-7320.
47. Ellison V, Abrams H, Roe T, Lifson J & Brown P (1990) Human immunodeficiency in a cell-free system. Journal of Virology 64: 2711-2715.
48. Engelman A & Craigie R (1992) Identification of conserved amino acid residues critical for human immunodeficiency virus type I integrase function in vino. Journal of Virology 66: 6361-6169.
49. Engelman A & Craigie R (1995) Efficient magnesium-dependent human immunodeficiency virus type 1 integrase activity. Journal of Virology 69: 5908-5911.
50. Engelman A, Mizuuchi K & Craigie R (1991) HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell 67: 1211-1221.
51. Engelman A, Bushman FD & Craigie R (1993) Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex. EMBO Journal 12: 3269-3275.
52. Engelman A, Hickman AB & Craigie R (1994) The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. Journal of Virology 68: 5911-5917.
53. Engelman A, Englund G, Orenstein JM, Martin MA & Craigie R (1995) Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. Journal of Virology 69: 2729-2736.
54. Engelman A, Liu Y, Chen H, Farzan M & Dyda F (1997) Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase. Journal of Virology 71: 3507-3514.
55. Farnet CM & Haseltine WA (1991) Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. Journal of Virology 65: 1910-1915.
56. Farnet CM, Wang B, Lipford JR & Bushman FD (1996a) Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules. Proceedings of the National Academy of Sciences, USA 93: 9742-9747.
57. Farnet CM & Bushman FD (1996b) HIV cDNA integration: molecular biology and inhibitor development. AIDS 10 (supplement A) 53-511.
58. Fayet O, Ramond P, Polard P, Prère MF & Chandler M (1990) Functional similarities between retroviruses and the IS3 family of bacterial insertion sequences? Molecular Microbiology 4: 1771-1777.
59. Fesen MR, Kohn KW, Leteurtre F & Pommier Y (1993) Inhibitors of human immunodeficiency virus integrase. Proceedings of the National Academy of Sciences, USA 90: 2399-2403.
60. Fesen MR, Pommier Y, Leteurtre F, Hiroguchi S, Yung J & Kohn KW (1994) Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochemical Pharmacology 48: 595-608.
61. Fitzgerald ML, Vora AC, Zeh WG & Grandgenett DP (1992) Concerted integration of viral DNA termini by purified avian mveloblastosis virus integrase. Journal of Virology 66: 6257-6263.
62. Fletcher TM, Brichacek B, Sharova N, Newman MA, Stivahtis G, Sharp PM, Emerman M, Hahn BH & Stevenson M (1996) Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO Journal 15: 6155-6165.
63. Gallay P, Swingler S, Song J, Bushman F & Trono D (1995) HIV nuclear import is governed by the phophotyrosine-mediated binding of the matrix to the core domain of integrase. Cell 83: 569-576.
64. Goff SP (1992) Genetic of retroviral integration. Annual Review of Genetics 26: 527-544.
65. Goodarzi G, Im G-J, Brackmann K & Grandgenett D (1995) Concerted integration of retrovirus-like DNA by human immunodeficiency virus type 1 integrase. Journal of Virology 69: 1090-1097.
66. Goodarzi G, Chiu R, Brackmann K, Kohn KW, Pommier Y & Grandgenett DP (1997) Host site selection for concerted integration by human immunodeficiency virus type 1 virions in vitro. Virology 231: 210-217.
67. Gupta M, Fujimori A & Pommier Y (1995) Eukaryotic DNA topoisomerases I. Biochemica at Biophysica Acta 1262: 1-14.
68. Hazuda DJ, Wolfe AL, Hastings JC, Robbins HL, Graham PL, LaFemina RL & Emini EA (1994a) Viral long terminal repeat substrate binding characteristics of the human immunodeficiency virus type 1 integrase. Journal of Biological Chemistry 269: 3999-4004.
69. Hazuda DJ, Hastings JC, Wolfe AL & Emini EA (1994b) A novel assay for the DNA strand-transfer reaction of HIV-1 integrase. Nucleic Acids Research 22: 1121-1122.
70. Hazuda D, Felock P, Hastings J, Pramanik B, Wolfe A, Goodarzi G, Vora A, Brackmann K & Grandgenett D (1997) Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds. Journal of Virology 71: 807-811.
71. Hong H, Neamati N, Wang S, Nicklaus M, Mazumder A, Zhao H, Burke TR, Pommier Y & Milne GWA (1997) Discovery of human immunodeficiency virus type 1 integrase inhibitors by pharmacophore searching. Journal of Medicinal Chemistry 40: 930-936.
72. Jenkins TM, Engelman A, Ghirlando R & Craigie R (1996) A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl-terminal domains in multimerization. Journal of Biological Chemistry 271: 7712-7718.
73. Jonsson CB, Donzella GA & Roth MJ (1993) Characterization of the forward and reverse integration reactions of the Moloney murine leukemia virus integrase protein purified from Escherichia coli. Journal of Biological Chemistry 268: 1462-1469.
74. Kalpana GV & Goff SP (1994) Protein-protein interactions of HIV-1 IN: INI-1 (IN Interactor-1), a novel human gene with sequence similarity to yeast transcription factor SNF5. Journal of Cellular Biochemistry 18B: 27.
75. Kalpana GV, Marmon S, Wang W, Crabtree GR & Goff SP (1994) Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266: 2002-2006.
76. Katzman M & Sudol M (1996) Influence of subterminal viral DNA nucleotide on differential susceptibility to cleavage by human immunodeficiency virus type 1 and visna virus integrases. Journal of Virology 70: 9069-9073.
77. Katzman M, Katz RA, Skalka AM & Leis J (1989) The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. Journal of Virology 63: 5319-5327.
78. Khan E, Mack JP, Katz RA, Kulkosky J & Skalka AM (1991) Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Research 19: 851-860; Erratum 19: 1358.
79. Kitamura Y, Ha Lee YM & Coffin JM (1992) Nonrandom integration of retroviral DNA in vitro: effect of CpG methylation. Proceedings of the National Academy of Sciences, USA 89: 5532-5536.
80. Kukolj G & Skalka AM (1995) Enhanced and coordinated processing of synapsed viral DNA ends by retroviral integrases in vitro. Genes and Development 9: 2556-2567.
81. Kukolj G, Jones KS & Skalka AM (1997) Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases. Journal of Virology 71: 843-847.
82. Kulkosky J & Skalka AM (1990) HIV DNA integration: observations and inferences. Journal of Acquired Immune Deficiency Syndromes 3: 839-851.
83. Kulkosky J, Jones KS, Katz RA, Mack JP & Skalka AM (1992) Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Molecular and Cellular Biology 12: 2331-2338.
84. LaFemina RL, Callahan PL & Cordingley MG (1991) Substrate specificity of recombinant human immunodeficiency virus integrase protein. Journal of Virology 65: 5624-5630.
85. LaFemina RL, Schneider CL, Robbins HL, Callahan PL, LeGrow K, Roth E, Schleif WA & Emmi EA (1992) Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. Journal of Virology 66: 7414-7419.
86. LaFemina RL, Graham PL, LeGrow K, Hastings JC, Wolfe A, Young SD, Emini EA & Hazuda D (1995) Inhibition of human immunodeficiency virus integrase by bis-catechols. Antimicrobial Agents and Chemotherapy 39: 320-324.
87. Lapadat-Tapolsky M, De Rocquigny H, Van Gent D, Roques B, Plasterk R & Darlix J-L (1993) Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Research 21: 831-839.
88. Leavitt AD, Rose RB & Varmus HE (1992) Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae. Journal of Virology 66: 2359-2368.
89. Leavitt AD, Shiue L & Varmus HE (1993) Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro. Journal of Biological Chemistry 268: 2113-2119.
90. Lee MS & Craigie R (1994) Protection of retroviral DNA from autointegration: involvement of a cellular factor. Proceedings of the National Academy of Sciences, USA 91: 9823-9827.
91. Lee SP & Han MK (1996) Zinc stimulates Mg2+-dependent 3′-processing activity of human immunodeficiency virus type 1 integrase in vitro. Biochemistry 35: 3837-3844.
92. Lee SP, Kim HG, Censullo ML & Han MK (1995a) Characterization of Mg2+-dependent 3′-processing activity for human immunodeficiency virus typel integrase in vitro: real-time kinetic studies using fluorescence resonance energy transfer. Biochemistry 34: 10205-10214.
93. Lee SP, Censullo ML, Kim HG & Han MK (1995b) Substrate-length-dependent activities of human immunodeficiency type 1 integrase in vitro: differential DNA binding affinities associated with different lengths of substrates. Biochemistry 34: 10215-10223.
94. Lee SP, Xiao J, Knutson JR, Lewis MS & Han MK (1997) Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. Biochemistry 36: 173-180.
95. Lee-Huang S, Huang PL, Huang PL, Bourinbaiar AS, Chen H-C & Kung H-F (1995) Inhibition of the integrase immunodeficiencv virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proceedings of the National Academy of Sciences, USA 92: 8818-8822.
96. Lew-Mintz P, Duan L, Zhang H, Hu B, Dornadula G, Zhu M, Kulkosky J, Bizub-Bender D, Skalka AM & Pomerantz RJ (1996) Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. Journal of Virology 70: 8821-8832.
97. Lipford JR, Worland ST & Farnet CM (1994) Nucleotide binding bv the HIV-1 integrase protein in vitro. Journal of AIDS 7: 1215-1223.
98. Lodi PJ, Ernst JA, Kuszewski J, Hickman AB, Engelman A, Craigie R, Clore GM & Gronenborn AM (1995) Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry 34: 9826-9833.
99. Lutzke RAP, Vink C & Plasterk RHA (1994) Characterization of the minimal DNA-binding domain of the HIV integrase protein. Nucleic Acids Research 22: 4125-4131.
100. Lutzke RAP, Eppens NA, Weber PA, Houghten RA & Plasterk RHA (1995) Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library. Proceedings of the National Academy of Sciences, USA 92: 11456-11460.
101. Mazumder A & Pommier Y (1995) Processing of deoxyuridine mismatches and abasic sites by human immunodeficiency virus type I integrase. Nucleic Acids Research 23: 2865-2871.
102. Mazumder A, Engelman A, Craigie R, Fesen M & Pommier Y (1994a) Intermolecular disintegration and intramolecular strand transfer activities of wild-type and mutant HIV-1 integrase. Nucleic Acids Research 22: 1037-1043.
103. Mazumder A, Gupta M & Pommier Y (1994b) Methylphosphonodiester substitution near the conserved CA dinucleotide in the HIV LTR alters both the extent of 3′-processing and choice of nucleophile by HIV-1 integrase. Nucleic Acids Research 22: 4441-4448.
104. Mazumder A, Cooney D, Agbaria R, Gupta M & Pommier Y (1994c) Inhibition of human immunodeficiency virus type 1 integrase by 3′-azido-3′-deoxythymidylate. Proceedings of the National Academy of Sciences, USA 91: 5771-5775.
105. Mazumder A, Gupta M, Perrin DM, Sigman DS, Rabinovitz M & Pommier Y (1995a) Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation: the phenanthrolinecuprous complex. AIDS Research and Human Retroviruses 11: 115-125.
106. Mazumder A, Gazit A, Levitzki A, Nicklaus M, Yung J, Kohlhagen G & Pommier Y (1995b) Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase. Biochemistry 34: 15111-15121.
107. Mazumder A, Raghavan K, Weinstein J, Kohn KW & Pommier Y (1995c) Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochemical Pharmacology 49: 1165-1170.
108. Mazumder A, Neamati N, Ojwang JO, Sunder S, Rando RF & Pommier Y (1996a) Inhibition of human immunodeficiency virus type 1 integrase by guanosine quartet structures. Biochemistry 43: 13762-13771.
109. Mazumder A, Neamati N, Pilon A, Sunder S & Pommier Y (1996b) Chemical trapping of ternary complexes of human immunodeficiency virus type 1 integrase, divalent metal, and DNA substrates containing an abasic site. Journal of Biological Chemistry 271: 27330-27338.
110. Mazumder A, Neamati N, Sommadossi J-P, Gosselin G, Schinazi R, Imbach J-L & Pommier Y (1996c) Effects of nucleotide analogs on human immunodeficiency virus type 1 integrase. Molecular Pharmacology 49: 621-628.
111. Mazumder A, Wang S, Neamati N, Nicklaus M, Sunder S, Chen J, Milne G, Rice WG, Burke TR & Pommier Y (1996d) Antiretroviral agent as inhibitors of both human immunodeficiency virus type 1 integrase and protease. Journal of Medicinal Chemistry 39: 2472-2481.
112. Mazumder A, Neamati N, Sunder S, Owen J & Pommier Y (1997a) Retroviral integrase: a novel target in antiviral drug development: basic in vitro assays with the purified enzyme. In Methods in Cellular and Molecular Biology: Antiviral Evaluation. Edited by D Kinchington and R Schinazi. Totowa, NJ: Humana Press (in press).
113. Mazumder A, Uchida H, Neamati N, Sunder S, Jaworska-Maslanka M, Wickstrom E, Zeng F, Jones RA, Mandes RF, Chenault HK & Pommier Y (1997b) Probing interactions between viral DNA and human immunodeficiency virus type 1 integrase using dinucleotides. Molecular Pharmacology 51: 567-575.
114. Miller MD, Farnet CM & Bushman FD (1997) Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. Journal of Virology 71: 5382-5390.
115. Mizuuchi K (1992) Polynucleotidyl transfer reactions in transpositional DNA recombination. Cell 267: 21273-21276.
116. Mouscadet J-F, Carteau S, Goulaouic H, Subra F & Auclair C (1994a) Triplex-mediated inhibition of HIV DNA integration in vitro. Journal of Biological Chemistry 269: 21634-21638.
117. Mouscadet J-F, Ketterlé C, Goulaouic H, Carteau S, Subra F, Le Bret M & Auclair C (1994b) Triple helix formation with short oligonucleotide-intercalator conjugates matching the HIV-1 U3 LTR end sequence. Biochemistry 33: 4187-4196.
118. Müller B, Jones KS, Merkel GW & Skalka AM (1993) Rapid solution assays for retroviral integration reactions and their use in kinetic analyses of wild-type and mutant Rous sarcoma virus integrases. Proceedings of the National Academy of Sciences, USA 90: 11633-11637.
119. Müller H-P & Varmus HE (1994) DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes. EMBO Journal 13: 4704-4714.
120. Murphy JE & Goff SP (1992) A mutation at one end of Moloney murine leukemia virus DNA blocks cleavage of both ends by the viral integrase in vivo. Journal of Virology 66: 5092-5095.
121. Natarajan K, Singh S, Burke TR, Grunberger D & Aggarwal BB (1996) Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proceedings of the National Academy of Sciences, USA 93: 9090-9095.
122. Neamati N, Sunder S & Pommier Y (1997a) Design and discovery of HIV-1 integrase inhibitors. Drug Discovery Today 2: 487-498..
123. Neamati N, Mazumder A, Zhao H, Sunder S, Burke TR, Schultz RJ & Pommier Y (1997b) Diarylsulfones, a novel class of HIV-1 integrase inhibitors. Antimicrobial Agents and Chemotherapy 41: 385-393.
124. Neamati N, Hong H, Mazumder A, Wang S, Sunder S, Nicklaus MC, Milne GWA, Proska B & Pommier Y (1997c) Depside and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. Journal of Medicinal Chemistry 40: 942-951.
125. Nicklaus M, Neamati N, Hong H, Mazumder A, Sunder Y, Chen J, Milne GWA & Pommier Y (1997) HIV-1 integrase pharmacophore: discovery of inhibitors through 3D database searching. Journal of Medicinal Chemistry 40: 920-929.
126. Nilsen BM, Haugan IR, Berg K, Olsen L, Brown PO & Helland DE (1996) Monoclonal antibodies against human immunodeficiency virus type 1 integrase: epitope mapping and differential effects on integrase activities in vitro. Journal of Virology 70: 1580-1587.
127. Ojwang JO, Buckheit RW, Pommier Y, Mazumder A, de Vreese K, Esté IA Reymen D, Pallansch LA, Lackman-Smith C, Wallace TL, De Clercq E, McGrath MS & Rando RF (1995) T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1. Antimicrobial Agents and Chemotherapy 39: 2426-2435.
128. Ouali M, Bouziane M, Ketterle C, Gabarro-Arpa J, Auclair C & Le Bret M (1996) A molecular mechanics and dynamics study of alternate triple-helices involving the integrase-binding site of the HIV-1 virus and oligonucleotides having a 3′-3′ internucleotide junction. Journal of Biomolecular Structure and Dynamics 13: 835-853.
129. Pemberton IK, Buckle M & Buc H (1996) The metal ion-induced cooperative binding of HIV-1 integrase to DNA exhibits a marked preference for Mn(II) rather than Mg(II). Journal of Biological Chemistry 271: 1498-1506.
130. Pommier Y (1997) DNA topoisomerase II inhibitors. In Cancer Therapeutics: Experimental and Clinical Agents. Edited by BA Teicher. Totowa, NJ: Humana Press, pp. 153-174.
131. Pruss D, Bushman FD & Wolffe AP (1994a) Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proceedings of the National Academy of Sciences, USA 91: 5913-5917.
132. Pruss D, Reeves R, Bushman FD & Wolffe AP (1994b) The influence of DNA and nucleosome structure on integration events directed by HIV integrase. Journal of Biological Chemistry 269: 25031-25041.
133. Pryciak PM & Varmus HE (1992) Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 69: 769-780.
134. Pryciak PM, Sil A & Varmus HE (1992) Retroviral integration into minichromosomes in vitro. EMBO Journal 11: 291-303.
135. Reicin AS, Kalpana G, Paik S, Marmon S & Goff S (1995) Sequences in the human immunodeficiency virus type 1 U3 region required for in vivo and in vitro integration. Journal of Virology 69: 5904-5907.
136. Rice P, Craigie R & Davies DR (1996) Retroviral integrases and their cousins. Current Opinion in Structural Biology 6: 76-83.
137. Robinson WE, Cordeiro M, Abdel-Malek S, Jia Q, Chow SA, Reinecke MG & Mitchell WM (1996a) Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase. Molecular Pharmacology 50: 846-855.
138. Robinson WE, Reinecke MG, Abdel-Malek S, Jia Q & Chow SA (1996b) Inhibitors of HIV-1 replication that inhibit HIV integrase. Proceedings of the National Academy of Sciences, USA 93: 6326-6331.
139. Roe T, Reynolds TC, Yu G & Brown PO (1993) Integration of murine leukemia virus DNA depends on mitosis. EMBO Journal 12: 2099-2108.
140. Roe T, Chow SA & Brown PO (1997) 3′-End processing and kinetics of 5′-end joining during retroviral integration in vivo. Journal of Virology 71: 1334-1340.
141. Schauer M & Billich A (1992) The N-terminal region of HIV-1 integrase is required for integration activity, but not for DNA-binding. Biochemical and Biophysical Research Communications 185: 874-880.
142. Schiff RD & Grandgenett DP (1978) Virus-coded origin of a 32,000-dalton protein from avian retrovirus cores: structural relatedness of p32 and the beta polypeptide of the avian retrovirus DNA polymerase. Journal of Virology 28: 279-291.
143. Scottoline BP, Chow S, Effison V & Brown PO (1997) Disruption of the terminal base pairs of retroviral DNA during integration. Genes and Development 11: 371-382.
144. Sherman PA & Fyfe JA (1990) Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity. Proceedings of the National Academy of Sciences, USA 87: 5119-5123.
145. Sherman PA, Dickson ML & Fyfe JA (1992) Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions. Journal of Virology 66: 3593-3601.
146. Shih C-C, Stoye JF & Coffin JM (1988) Highly preferred targets for retrovirus integration. Cell 53: 531-538.
147. Shin C-C, Taddeo WA, Haseltine WA & Farnet CM (1994) Genetic analysis of the human immunodeficiency virus type 1 integrase protein. Journal of Virology 68: 1633-1642.
148. Sourgen F, Maroun RG, Frere V, Bouziane M, Auclair C, Troalen F & Fermandjian S (1996) A synthetic peptide from the human immunodeficiency virus type-1 integrase exhibits coiled-coil properties and interferes with the in vitro integration activity of the enzyme. Correlated biochemical and spectroscopic results. European Journal of Biochemistry 240: 765-773.
149. Stanwell C, Burke TR & Yuspa SH (1995) Erbstatin analogue methyl 2,5-dihydroxycinnamate cross-links proteins and is cytotoxic to normal and neoplastic epithelial cells by a mechanism independent of tyrosine kinase inhibition. Cancer Research 55: 4950-4956.
150. Stanwell C, Ye B, Yuspa SH & Burke TR (1996) Cell protein-crosslinking by erbstatin and related compounds. Biochemical Pharmacology 52: 475-480.
151. Stevens SW & Griffith JD (1996) Sequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration. Journal of Virology 70: 6459-6462.
152. Stevenson M (1994) Identification of factors that govern HIV-1 replication in non-dividing cells. AIDS Research and Human Retroviruses 10: S11-S15.
153. Stevenson M, Stanwick TL, Dempsey MP & Lamonica CA (1990) HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO Journal 9: 1551-1560.
154. Taddeo B, Carlini F, Verani P & Engelman A (1996) Reversion of a human immunodeficiency virus type 1 integrase mutant at a second site restores enzyme function and virus infectivity. Journal of Virology 12: 8277-8284.
155. van den Ent FMI, Vink C & Plasterk RHA (1994) DNA substrate requirements for different activities of the human immunodeficiency virus type 1 integrase protein. Journal of Virology 68: 7825-7832.
156. van Gent DC, Elgersma Y, Bolk MW, Vink C & Plasterk RHA (1991) DNA binding properties of the integrase proteins of human immunodeficiency viruses types 1 and 2. Nucleic Acids Research 19: 3821-3827.
157. van Gent DC, Oude Groeninger AAM & Plasterk RHA (1992) Mutational analysis of the integrase protein of human immunodeficiency virus type 2. Proceedings of the National Academy of Sciences, USA 89: 9598-9602.
158. van Gent DC, Vink C, Oude Groeninger AAM & Plasterk RHA (1993) Complementation between HIV integrase proteins mutated in different domains. EMBO Journal 12: 3261-3267.
159. Vijaya S, Steffen DL & Robinson HL (1986) Acceptor sites for retroviral integrations map near DNase I-hypersensitive sites in chromatin. Journal of Virology 60: 665-697.
160. Vink C & Plasterk RHA (1993) The human immunodeficiency virus integrase protein. Trends in Genetics 9: 433-437.
161. Vink C, Yeheskiely E, van der Marel GA, van Boom JH & Plasterk RHA (1991a) Site-specific hydrolysis and alcoholysis of human immunodeficiency virus DNA termini mediated by the viral integrase protein. Nucleic Acids Research 19: 6691-6698.
162. Vink C, van Gent DC, Elgersma Y & Plasterk RHA (1991b) Human immunodeficiency virus integrase protein requires a subterminal position for its viral DNA recognition sequence for efficient cleavage. Journal of Virology 65: 4636-4644.
163. Vink C, Oude Groeninger AAM & Plasterk RHA (1993) Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. Nucleic Acids Research 21: 1419-1425.
164. Vink C, Lutzke RAP & Plasterk RHA (1994a) Formation of a stable complex between the human immunodeficiency virus integrase protein and viral DNA. Nucleic Acids Research 22: 4103-4110.
165. Vink C, Banks M, Bethell R & Plasterk RHA (1994b) A high-throughput, non-radioactive microtiter plate assay for activity of the human immunodeficiency virus integrase protein. Nucleic Acids Research 22: 2176-2177.
166. von Schwedler U, Kornbluth RS & Trono D (1994) The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allow the establishment of infection in macrophages and quiescent T lymphocytes. Proceedings of the National Academy of Sciences, USA 91: 6992-6996.
167. Vora AC & Grandgenett DP (1995) Assembly and catalytic properties of retrovirus integrase-DNA complexes capable of efficiently performing concerted integration. Journal of Virology 69: 7483-7488.
168. Wang W, Cote J, Xue Y, Zhou S, Khavari PA, Biggar SR, Muchardt C, Kalpana GV, Goff SP, Yaniv M, Workman JL & Crabtree GR (1996) Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO Journal 15: 5370-5382.
169. Wiskerchen M & Muesing MA (1995a) Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. Journal of Virology 69: 376-386.
170. Wiskerchen M & Muesing MA (1995b) Identification and characterization of a temperature-sensitive mutant of human immunodeficiency virus type 1 by alanine scanning mutagenesis of the integrase gene. Journal of Virology 69: 597-601.
171. Withers-Ward ES, Kitamura Y, Barnes JP & Coffin JM (1994) Distribution of target for avian retrovirus DNA integration in vivo. Genes and Development 8: 1473-1487.
172. Woerner AM, Klutch M, Levin JG & Marcus-Sekura CJ (1992) Localization of DNA binding activity of HIV-1 integrase to the c-terminal half of the proteins. AIDS Research and Human Retroviruses 8: 297-304.
173. Woerner AM & Marcus-Sekura CJ (1993) Characterization of a DNA binding domain in the C-terminus of HIV-1 integrase by deletion mutagenesis. Nucleic Acids Research 21: 3507-3511.
174. Yang W & Steitz TA (1995) Recombining the structures of HIV integrase, RuvC and RNase H. Current Biology 3: 131-134.
175. Yoshinaga T & Fujiwara T (1995) Different roles of bases within the integration signal sequence of human immunodeficiency virus type 1 in vitro. Journal of Virology 69: 3233-3236.
176. Yoshinaga T, Kimura-Ohtani Y & Fujiwara T (1994) Detection and characterization of a functional complex of human immunodeficiency virus type 1 intergrase and its substance by UV cross-linking. Journal of Virology 68: 5690-5697.
177. Zhao H, Neamati N, Hong H, Mazumder A, Wang S, Sunder S, Milne GWA, Pommier Y & Burke Jr TR (1996) Coumarin-based inhibitors of HIV integrase. Journal of Medicinal Chemistry 40: 242-249.
178. Zhao H, Neamati N, Sunder S, Hong H, Wang S, Milne GWA, Pommier Y & Burke T (1997a) Hydrazide-containing inhibitors of HIV-1 integrase. Journal of Medicinal Chemistry (in press).
179. Zhao H, Neamati N, Mazumder A, Sunder S, Pommier Y & Burke T (1997b) Arylamide inhibitors of HIV-1 integrase. Journal of Medicinal Chemistry 40: 1186-1194.
180. Zheng R, Jenkins TM & Craigie R (1996) Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proceedings of the National Academy of Sciences, USA 93: 13659-13664.